Levomecor Inc.
Clinical trials sponsored by Levomecor Inc., explained in plain language.
-
New depression pill shows promise in early trial
Symptom relief TerminatedThis study tested a new drug called REL-1017 as an extra treatment for people with major depression who didn't get enough help from standard antidepressants. The trial was stopped early after enrolling 27 adults. Researchers measured changes in depression symptoms using a standar…
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated May 17, 2026 07:39 UTC
-
Depression drug trial halted mid-study
Symptom relief TerminatedThis study tested whether adding a daily pill called REL-1017 to a person's usual antidepressant could better relieve major depression symptoms. About 236 adults with depression that wasn't fully controlled by their current medication took either REL-1017 or a placebo. The trial …
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC